Adalimumab-ryvk
Adalimumab-ryvk is biosimilarto HUMIRA(adalimumab).
Approved
Approval ID
dce1590f-9e47-4c4d-9437-cfb18b779a75
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Feb 28, 2025
Manufacturers
FDA
Quallent Pharmaceuticals Health LLC
DUNS: 815564528
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
adalimumab-ryvk
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code82009-156
Application NumberBLA761299
Product Classification
M
Marketing Category
C73585
G
Generic Name
adalimumab-ryvk
Product Specifications
Route of AdministrationSUBCUTANEOUS
Effective DateFebruary 28, 2025
FDA Product Classification
adalimumab-ryvk
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code82009-158
Application NumberBLA761299
Product Classification
M
Marketing Category
C73585
G
Generic Name
adalimumab-ryvk
Product Specifications
Route of AdministrationSUBCUTANEOUS
Effective DateFebruary 28, 2025
FDA Product Classification